Status:
WITHDRAWN
OPIE in the Thin Interventricular Septum
Lead Sponsor:
NYU Langone Health
Conditions:
Hypertrophic Cardiomyopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a follow up investigation to our previous study entitled "On-pump intraoperative echocardiography (OPIE)" (clinicaltrials.gov NCT03094325) whereby we determined that left ventricular septal th...
Eligibility Criteria
Inclusion
- All hypertrophic cardiomyopathy patients, inclusive of male and female and all racial/ethnic origins, age 18 or older who are scheduled to receive a septal myectomy with a preoperative transthoracic echocardiograph suggesting an interventricular septal width of less than 2.0 cm.
Exclusion
- Those hypertrophic cardiomyopathy patients who are scheduled to receive a septal myectomy who are less than 18 years old or whose preoperative transthoracic echocardiograph suggests an interventricular septal width of greater than 2.0 cm.
Key Trial Info
Start Date :
September 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04050579
Start Date
September 15 2020
End Date
May 30 2025
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016